Skip to main content

MintNeuro

MintNeuro designs purpose-built, ultra-low-power semiconductor chips for neural devices, enabling smaller, safer, and more scalable implants and wearables. Their modular chip platform supports neural signal acquisition, electrical stimulation, on-chip processing, and wireless data transfer for applications from epilepsy monitoring to brain-computer interfaces. The company works with medical device firms and researchers to integrate these chips into minimally invasive neural technologies.

Traction 10/10
London, United Kingdom · HQ
Founded 2022297K+ followers
  • Semiconductor
  • Medical Devices
  • Healthcare Technology
  • Hardware
  • Biotechnology
Updated 29 days ago

Funding

Raised to date

$6.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

across 2 rounds

EH+6

$5M · Seed

Announced Oct 2026 · from article date

Disclosed cumulative: $6.3M

2/2

Founders

2 founders

Dorian Haci

CEO

Timothy Constandinou

Co-founder

Product

Problem

Current neural implants for treating neurological conditions often require invasive surgical procedures due to their size and complexity. These implants also have limited capabilities in sensing, processing, and modulating neural activity, hindering effective treatment and monitoring of neurological disorders.

Solution

MintNeuro is developing next-generation neural implants utilizing scalable semiconductor technology to address the limitations of existing solutions. Their compact, low-power bioelectronic implants enable minimally invasive procedures, reducing patient risk and improving accessibility. By focusing on advanced integrated circuits, MintNeuro's technology facilitates high-performance sensing, processing, and modulation of neural activity. The company's modular chiplet approach allows for customized solutions that can be efficiently combined to address a wide range of neurological conditions, paving the way for more effective and less invasive therapeutic interventions.

Target Audience

MintNeuro's primary target audience includes medical device companies, system integrators building active implantable medical devices (AIMDs) and brain-computer interfaces (BCIs), innovative neurotech companies building wearable devices, and research institutions and clinical groups translating neurotechnologies.

Features

  • Ultra-low power integrated circuits engineered for high performance and long-term reliability
  • Wireless communication capabilities for seamless data transfer and remote monitoring
  • Miniaturized implantable devices designed for minimally invasive surgical procedures
  • Modular design using specialized "chiplets" for sensing, stimulation, and processing
  • Customizable solutions tailored to specific neurological conditions and patient needs
  • Focus on both sensing applications (e.g., epilepsy neuromonitoring, brain-computer interfaces) and neuromodulation
  • Development of a "neural chipset" with function-specific chips designed to work together across multiple applications
  • On-chip signal processing and data reduction capabilities
  • Power management integrated with wireless data transfer
  • Designed to regulatory standards of size, power, and safety
  • Manufactured through close partnership with trusted foundries
  • Scalable from research prototypes to commercial devices
This profile is AI-generated and may contain inaccuracies.